Articles published by ImmunoPrecise Antibodies Ltd.
IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023
March 16, 2023
Via Business Wire
Tickers
IPA
IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023
December 15, 2022
Via Business Wire
Tickers
IPA
ImmunoPrecise Antibodies Announces Grant of Stock Options
January 17, 2022
Via Business Wire
Tickers
IPA
ImmunoPrecise Antibodies Announces Grant of Stock Options
January 11, 2022
Via Business Wire
Tickers
IPA
ImmunoPrecise Antibodies Announces Grant of Stock Options
January 03, 2022
Via Business Wire
Tickers
IPA
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2022
December 13, 2021
Via Business Wire
Tickers
IPA
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2022
December 07, 2021
Via Business Wire
Tickers
IPA
ImmunoPrecise Update on its SARS-CoV-2 PolyTope™ Multi-Antibody Cocktail Development Program
November 30, 2021
Via Business Wire
Tickers
IPA
Via Business Wire
Tickers
IPA
ImmunoPrecise Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2022
September 09, 2021
Via Business Wire
Tickers
IPA
ImmunoPrecise’s Dutch Subsidiary Receives French Research Tax Credit (CIR) Accreditation
September 08, 2021
Via Business Wire
Tickers
IPA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free